U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Previous Screen

Vandetanib Tablets
Status: Currently in Shortage
»Date first posted: 07/13/2022
»Therapeutic Categories: Oncology

Expand all

Sanofi (New 07/13/2022)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Vandetanib (Caprelsa) 100mg Tablets (NDC 58468-7820-3) Out of stock. Shortage of an active ingredient
Vandetanib (Caprelsa) 300mg Tablets (NDC 58468-7840-3) Out of stock. Shortage of an active ingredient
Back to Top